Corcept Therapeutics Incorporated (CORT)
- Exchange
- NASDAQ
- Symbol
- CORT
- Sector
- Life Sciences
- Industry
- Pharmaceutical Preparations
- Description
- Corcept Therapeutics Incorporated discovers, develops, and markets drugs for the treatment of severe metabolic, cancer, and psychiatric disorders in the United States. The company is headquartered in Menlo Park, California.
- Country
- USA
Stock price
At close: November 22, 2024
-
Open56.20
-
High57.71
-
Low56.14
-
Close57.54
-
Volume676,106
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
24.74
Receivables turnover
11.26
Payables turnover
10.99
Working capital turnover
1.36
Days of inventory on hand (DOH)
14.76
Days of sales outstanding (DSO)
32.40
Number of days of payables
33.21
Fixed asset turnover
2,473.72
Total asset turnover
0.78
Current ratio
4.39
Quick ratio
3.93
Cash ratio
3.52
Cash conversion cycle
13.95
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.23
Interest coverage
—
Gross profit margin
60.36%
Operating profit margin
22.24%
Pretax margin
25.82%
Net profit margin
22.00%
Operating return on assets (Operating ROA)
17.26%
Return on assets (ROA)
17.08%
Return on total capital
21.17%
Return on equity (ROE)
20.95%